Suppressor of cytokine signaling 3 is a negative regulator for neointimal hyperplasia of vein graft stenosis

Journal of Vascular Research

Volumn 51, Issue 2, 2014, Pages 132-143

  Xiang, Shui ^a,c   Liu, Jinping ^a   Dong, Nianguo ^a   Shi, Jiawei ^a   Xiao, Yaqiong ^a   Wang, Yu ^b   Hu, Xingjian ^a   Gong, Li ^a   Wang, Wenshuo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Central Hospital of Enshi Autonomous Prefecture   (China)

Author keywords

Coronary artery bypass graft; Vascular smooth muscle cell proliferation; Vein graft stenosis

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; GENE OVEREXPRESSION; HYPERPLASIA; IN VITRO STUDY; IN VIVO STUDY; MALE; NEOINTIMA; NEOINTIMAL HYPERPLASIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VEIN GRAFT DISEASE; VEIN GRAFT STENOSIS; WESTERN BLOTTING; ADENOVIRIDAE; VASCULAR SMOOTH MUSCLE CELL;

ANIMALS; CAROTID ARTERIES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; GRAFT OCCLUSION, VASCULAR; HYPERPLASIA; INFLAMMATION MEDIATORS; JUGULAR VEINS; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TIME FACTORS; TRANSFECTION; VASCULAR GRAFTING;

EID: 84897119019     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000355193     Document Type: Article

References (22)

1. Shuhaiber JH, Evans AN, Massad MG, Geha AS: Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery. Eur J Cardiothorac Surg 2002; 22: 387-396.
2. Mitra AK, Gangahar DM, Agrawal DK: Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol 2006; 84: 115-124.
3. Mitra AK, Agrawal DK: Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology. Pharmacogenomics 2006; 7: 1185-1198.
4. O'Sullivan LA, Liongue C, Lewis RS, Stephenson SE, Ward AC: Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease. Mol Immunol 2007; 44: 2497-2506.
5. Kile BT, Nicola NA, Alexander WS: Negative regulators of cytokine signaling. Int J Hematol 2001; 73: 292-298.
6. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A: A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997; 387: 921-924.
7. Sasaki A, Yasukawa H, Suzuki A, Kamizono S, Syoda T, Kinjyo I, Sasaki M, Johnston JA, Yoshimura A: Cytokine-inducible SH2 protein- 3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 1999; 4: 339-351.
8. Jo D, Liu D, Yao S, Collins RD, Hawiger J: Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Med 2005; 11: 892-898.
9. Tamiya T, Kashiwagi I, Takahashi R, Yasukawa H, Yoshimura A: Suppressors of cytokine signaling (SOCS) proteins and JAK/ STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol 2011; 31: 980-985.
10. Qin H, Holdbrooks AT, Liu Y, Reynolds SL, Yanagisawa LL, Benveniste EN: SOCS3 deficiency promotes M1 macrophage polarization and inflammation. J Immunol 2012; 189: 3439-3448.
11. Taleb S, Romain M, Ramkhelawon B, Uyttenhove C, Pasterkamp G, Herbin O, Esposito B, Perez N, Yasukawa H, Van Snick J, Yoshimura A, Tedgui A, Mallat Z: Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med 2009; 206: 2067-2077.
12. Ortiz-Munoz G, Martin-Ventura JL, Hernandez-Vargas P, Mallavia B, Lopez-Parra V, Lopez-Franco O, Munoz-Garcia B, Fernandez-Vizarra P, Ortega L, Egido J, Gomez-Guerrero C: Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29: 525-531.
13. Xiang S, Dong NG, Liu JP, Shi JW, Xiao YQ, Wang Y: Expression of suppressor of cytokine signaling 1/3 in pheripheral blood mononuclear cells of patients with coronary artery disease. Acta Med Unvi Sci Technol Huazhong 2012; 41: 152-155.
14. Xiang S, Dong NG, Liu JP, Shi JW, Xiao YQ, Wang Y: Construction of rat SOCS3 recombinant adenovirus vector and its expression in rat primary vascular smooth muscle cells. Acta Med Unvi Sci Technol Huazhong 2012; 41: 556-561.
15. Sterpetti AV, Cucina A, Lepidi S, Randone B, Corvino V, D'Angelo LS, Cavallaro A: Formation of myointimal hyperplasia and cytokine production in experimental vein grafts. Surgery 1998; 123: 461-469.
16. Neeli I: An essential role of the Jak-2/STAT-3/cytosolic phospholipase A(2) axis in platelet-derived growth factor BB-induced vascular smooth muscle cell motility. J Biol Chem 2004; 279: 46122-46128.
17. Croker BA, Metcalf D, Robb L, Wei W, Mifsud S, DiRago L, Cluse LA, Sutherland KD, Hartley L, Williams E, Zhang JG, Hilton DJ, Nicola NA, Alexander WS, Roberts AW: SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 2004; 20: 153-165.
18. Wong PKK: Socs-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J Clin Invest 2006; 116: 1571-1581.
19. Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, Kubo M, Yamashita A, Okabe M, Takeda K, Akira S, Matsumoto S, Toyonaga A, Sata M, Yoshimura A: CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med 2001; 193: 471-481.
20. Ogata H, Kobayashi T, Chinen T, Takaki H, Sanada T, Minoda Y, Koga K, Takaesu G, Maehara Y, Iida M, Yoshimura A: Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology 2006; 131: 179-193.
21. Niwa Y, Kanda H, Shikauchi Y, Saiura A, Matsubara K, Kitagawa T, Yamamoto J, Kubo T, Yoshikawa H: Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signaling in human hepatocellular carcinoma. Oncogene 2005; 24: 6406-6417.
22. Cui Q, Jiang W, Wang Y, Lv C, Luo J, Zhang W, Lin F, Yin Y, Cai R, Wei P, Qian C: Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma. Hepatology 2008; 47: 105-112.